Skip to main content
drug protocol number
D419AC00003
drug sponsor
AstraZeneca
drug study
MEDI4736+Tremelimumab
drug trial site
King Khalid University Hospital (Riyadh), King Fahad Specialist Hospital (Dammam)
drug status
Ongoing
drug phase